Pharmaceutical Development, Therapeutic Access, and Strategic Preparedness: New Paths for Public Health
A multi-country high-level policy dialogue in the context of the State of Health in the EU Voluntary Exchange, organized by the Italian Medicines Agency (AIFA) and the OECD with Luiss University.
AGENDA
Session 1. Crisis response and preparedness: lessons from pandemics
Moderator: European Observatory
9:30-9:45 Opening Remarks
Representative of the Italian Ministry of Health
9:45-10:15
Ana Maria Henao-Restrepo World Health Organization
Clinical trials integration and the COVID-19 experience
10:15-10:45
Rino Rappuoli Italian Anti-Pandemic Hub
Need for preparedness: R&D through public platforms
10:45-11:15
Francesco Branca World Health Organization
AMR as a silent pandemic: ways to fight it through the One Health Approach
11:15-11:30 Coffee Break
Session 2. Market dynamics and their discipline: horizon scanning
Moderator: OECD
11:30-12:00
Luca Arnaudo AIFA
Decentralizing advanced pharma productions for improving sustainable access
12:00-12:30
Dimitrios Florinis EC – DG SANTE
Joint pricing negotiations: on the EU JPAs and existing regional experiences
12:30-13:00
Peter Schedereit EC - DG COMP
Market regulation and competition: recent caselaw and developments
13:00-14:00 Light Lunch
Session 3. Global way(s) ahead
Moderator: Luiss University
14:00-14:30
Jens Grueger BCG
On pharmaceutical innovation, global value chains, and national security
14:30-15:00
Aaron Kesselheim Harvard University
How to support innovative and accessible pharmaceuticals
15:00-15:30
Nicola Magrini AIFA
Public health institutions as incubators for pharma access and innovation
